ACS Omega · 2021 · 34 citations · 26 references
PharmacyOncologyPharmaceuticsDrug DeliveryGene DeliveryGene TherapyCancer Drug DeliveryCancer NanomedicineLiposomal FormulationsLiposome-based DeliveryMicrorna BiologyNanocarriers For TherapeuticsCationic LiposomesEgfr InhibitionGene Delivery NanocarriersLiposomal Delivery SystemsLiposomal NanocarriersLiposome Delivery SystemsLiposomesMicrorna Targeting
-glycero-3-phosphoethanolamine, and cholesterol. The miR-7 liposomes had a suitable particle size, potential, and a high cellular uptake rate. MiR-7 encapsulated by liposomes could be effectively delivered to ovarian cancer cells and successfully targeted to the tumor site in a mouse xenograft model of ovarian cancer. In vitro and in vivo experiments revealed that the miR-7 liposomes had a significant ability to inhibit the growth, invasion, and migration of ovarian cancer, probably by inhibiting the expression of the epidermal growth factor receptor. Our studies of miR-7 liposomes demonstrated a safe and efficient microRNA delivery system for the gene therapy of ovarian cancer.
26
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2020 · 21.4K citations · Full text
The entry of nanoparticles into solid tumours
Shrey Sindhwani, Abdullah M. Syed, Jessica Ngai et al. · Nature Materials · 2020 · 1.6K citations
Pharmacy, Cancer Biology, Oncology +12
Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy
Quan Zhou, Shiqun Shao, Jinqiang Wang et al. · Nature Nanotechnology · 2019 · 813 citations
Pharmacy, Oncology, Pharmaceutics +12
Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA
Rebecca L. Ball, Khalid A. Hajj, Jamie Vizelman et al. · Nano Letters · 2018 · 307 citations